UNICEL® DXI 800 ACCESS IMMUNOASSAY SYSTEM
Report
- Report Number
- 2122870-2011-00862
- Event Type
- Malfunction
- Date Received
- March 29, 2011
- Date of Event
- April 3, 2008
- Report Date
- April 3, 2008
- Manufacturer
- BECKMAN COULTER INC.
- Product Code
- JHS
- PMA / PMN Number
- K023764
- Removal / Correction Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- LA, US
- Reporter Occupation
- OTHER
Narratives
THE SAMPLES WERE PLASMA COLLECTED INTO A BD PLASTIC LITHIUM HEPARIN GEL TUBE. SAMPLES WERE CENTRIFUGED VIA THE AUTOMATION LINE AND WERE TESTED USING THE PRIMARY TUBES. QC WAS IN RANGE ON EACH DAY SAMPLES WERE TESTED. SYSTEM CHECKS NOT PROVIDED. THE ISSUE REMAINS ISOLATED TO THIS ONE PATIENT. A FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED ON (B)(6) 2008 FOR THIS EVENT. THE FSE PERFORMED TROUBLESHOOTING AND PERFORMED ALL NECESSARY ALIGNMENTS. THE FSE VERIFIED REPAIRS PER ESTABLISHED PROCEDURES AND RESULTS MET PUBLISHED PERFORMANCE SPECIFICATIONS. THE CUSTOMER SENT THE PATIENT'S SAMPLES TO CUSTOMER PRODUCT LINE SUPPORT (CPLS) FOR FURTHER TESTING. CPLS TESTING CONFIRMED THE PRESENCE A HETEROPHILE INTERFERENT, WHICH IS OBSERVED AS THE ROOT CAUSE OF THIS EVENT. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS WITHIN THE DATE RANGE OF (B)(6) 2010 FOR ADDITIONAL REPORTABLE EVENTS.
A CUSTOMER CONTACTED BECKMAN COULTER INC., (BCI) IN REGARDS TO OBTAINING FALSELY ELEVATED CREATININE KINASE - MB (CKMB) RESULTS FOR MULTIPLE SAMPLES ON ONE PATIENT THAT WERE GENERATED BY THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM. THE ERRONEOUS RESULTS WERE REPORTED OUT OF THE LABORATORY. THERE HAS BEEN NO REPORT OF PATIENT INJURY, DEATH, OR CHANGE TO TREATMENT RECEIVED TO BCI TO DATE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | UNICEL® DXI 800 ACCESS IMMUNOASSAY SYSTEM | DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER | JHS | BECKMAN COULTER INC. | DXI 800 | N/A |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 81 YR |